Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain

Neurotoxicity Research

Volumn 6, Issue 1, 2004, Pages 51-56

  Malhotra, Anil K ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antipsychotic; Gene; Pharmacogenetics; Polymorphism; Schizophrenia; Weight

Indexed keywords

NEUROLEPTIC AGENT;

DRUG EFFECT; GENETICS; HUMAN; REVIEW; SCHIZOPHRENIA; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; HUMANS; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 3242745332     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033296     Document Type: Article

References (56)

1. Allison DB, J Kaprio, M Korkeila, M Koskenvuo, MC Neale and K Hayakawa (1996) The heritability of body mass index among an international sample of monozygotic twins reared apart. Int. J. Obes. Relat. Metab. Disord. 20, 501-506.
2. 2A receptor gene. Lancet 346, 281-282.
3. Arranz MJ, T Li, J Munro, X Liu, R Murray, DA Collier and RW Kerwin (1998) Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and cloza-pine response. Pharmacogenetics 8, 481-484.
4. Arranz MJ, AA Bolonna, J Munro, CJ Curtis, DA Collier and RW Kerwin (2000a) The serotonin transporter and clozapine response. Mol. Psychiatry 5, 124-125.
5. Arranz MJ, J Munro, J Birkett, A Bolonna, D Mancama, M Sodhi, KP Lesch, JF Meyer, P Sham, DA Collier, RM Murray and RW Kerwin (2000b) Pharmacogenetic prediction of clozapine response. Lancet 355, 1615-1616.
6. Basile VS, M Masellis, V De Luca, HY Meltzer and JL Kennedy (2002) 759C/ T genetic variation of 5HT(2C) receptor and cloza-pine-induced weight gain. Lancet 360, 1790-1791.
7. 2A receptor and response to clozapine. Lancet 346, 909.
8. Commuzzie AG and DB Allison (1998) The search for human obesity genes. Science 280, 1374-1377.
9. Comuzzie AG, J Blangero, MC Mahaney, BD Mitchell, JE Hixson, PB Samollow, MP Stern and JW MacCluer (1995) Major gene with sex-specific effects influences fat mass in Mexican Americans. Genet. Epidemiol. 12, 475-488.
10. Conley RR, WT Carpenter Jr and CA Tamminga (1997) Time to clozapine response in a standardized trial. Am. J. Psychiatry 154, 1243-1247.
11. Creese I, DR Burt and SH Snyder (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischiz-ophrenic drugs. Science 192, 481-483.
12. DeLisi LE and D Dauphinais (1989) Neuroleptic responsiveness in siblings concordant for schizophrenia. Arch. Gen. Psychiatry 46, 477.
13. 2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 12, 205-216.
14. Emsley RA, MC Roberts, S Rataemane, J Pretorius, PP Oosthuizen, J Turner, DJ Niehaus, N Keyter and DJ Stein (2002) Ethnicity and treatment response in schizophrenia, a comparison of 3 ethnic groups. J. Clin. Psychiatry 63, 9-14.
15. 2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel elec-trophoresis. JAMA 271, 204-208.
16. Kane JM (1999) Pharmacological treatment of schizophrenia. Biol. Psychiatry 46, 1396-1408.
17. Kaplan HI and BJ Sadock (1994) Kaplan and Sadock's Synopsis of Psychiatry, Behavioral Sciences Clinical Psychiatry, 7th Edition (Williams & Wilkins, Baltimore, MD).
18. 2 receptor explain the action of atypical antipsy-chotics? A new hypothesis. Am. J. Psychiatry 158, 360-369.
19. 4 receptor gene polymorphisms, relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. Eur. Neuropsychopharmacol. 1, 39-43.
20. Kuno E and AB Rothbard (2002) Racial disparities in antipsychot-ic prescription patterns for patients with schizophrenia. Am. J. Psychiatry 159, 567-572.
21. Lander ES, LM Linton, B Birren, C Nusbaum, MC Zody, J Baldwin, K Devon, K Dewar, M Doyle, W FitzHugh et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921.
22. 2A receptor gene. Am. J. Psychiatry 159, 1593-1595.
23. Lee JH, DR Reed and RA Price (1997) Familial risk ratios for extreme obesity, implications for mapping human obesity genes. Int. J. Obes. Relat. Metab. Disord. 21, 935-940.
24. Lin CH, SJ Tsai, YW Yu, HL Song, PC Tu, CB Sim, CP Hsu, KH Yang and CJ Hong (1999) No evidence for association of sero-tonin-2A receptor variant (102T/C) with schizophrenia or cloza-pine response in a Chinese population. NeuroReport 10, 57-60.
25. 2A receptor gene and the antipsychotic response to clozapine. Am. J. Psychiatry 153, 1092-1094.
26. 2C Cys23Ser polymorphism. NeuroReport 7, 2100-2102.
27. Malhotra AK, A Breier, D Goldman, L Picken and D Pickar (1998) The apolipoprotein E E4 allele is associated with blunting of ket- amine-induced psychosis in schizophrenia. Neuropsychopharmacology 19, 445-448.
28. 2 receptor gene and clozapine response. Schizophr. Res. 36, 92-93.
29. Masellis M, V Basile, HY Meltzer, JA Lieberman, S Sevy, FM Macciardi, P Cola, A Howard, F Badri, MM Nothen, W Kalow and JL Kennedy (1998) Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients. Neuropsychopharmacology 19, 123-132.
30. 6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia. Schizophr. Res. 47, 49-58.
31. Mata I, MJ Arranz, T Lai, D Mancama, J Arrondo, M Beperet, R Villavicencio, J Munro, S Osborne and RW Kerwin (2002) The serotonergic system influences individual's response to risperi-done. Am. J. Med. Genetics 114, 728.
32. 2 receptor gene locus, association with schizophrenia or treatment response not detected. Psychiatr. Genet. 6, 23-27.
33. 2A receptor and response to clozapine. Lancet 346, 908-909.
34. Nurnberger JI Jr, ES Gershon, S Simmons, M Ebert, LR Kessler, ED Dibble, SS Jimerson, GM Brown, P Gold, DC Jimerson, GM Brown, P Gold, DC Jimerson, JJ Guroff and FI Storch (1982) Behavioral, biochemical and neuroendocrine responses to amphetamine in normal twins and "well state" bipolar patients. Psychoneuroendocrinology 7, 163-176.
35. 4 receptor gene. CNS Spectrums 4, 30-56.
36. Ranade K, MS Chang, CT Ting, D Pei, CF Hsiao, M Olivier, R Pesich, J Herbert, YD Chen, VJ Dzau, D Curb, R Olshen, N Risch, DR Cox and D Botstein (2001) High-throughput geno-typing with single nucleotide polymorphisms. Genome Res. 11, 1262-1268.
37. 4 dopamine receptor (DRD4) gene does not predict response to clozapine. Arch. Gen. Psychiatry 51, 912-917.
38. 4 receptor gene. Neuropsychopharmacology 15, 491-496.
39. 2C receptor. NeuroReport 8, 1999-2003.
40. 2C receptor gene polymorphism. Lancet 359, 2086-2087.
41. Reynolds GP, Z Zhang and X Zhang (2003) Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am. J. Psychiatry 160, 677-679.
42. Schumacher J, TG Schulze, TF Wienker, M Rietschel and MM Nothen (2000) Pharmacogenetics of the clozapine response. Lancet 356, 506-507.
43. 4. Neuropsychopharmacology 7, 261-284.
44. 2 receptor gene. Am. J. Psychiatry 158, 802-804.
45. 4 receptor gene (DRD4) in schizophrenic patients. Am. J. Med. Genet. 60, 541-550.
46. 3 receptor gene and schizophrenia. Hum. Genet. 97, 714-719.
47. 2C receptor gene. NeuroReport 7, 169-172.
48. Strachan T and AP Read (1996) Mutation and instability of human DNA. Hum. Mol. Genet. 10, 241-273.
49. 2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients. Pharmacogenetics 10, 335-341.
50. 2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients. Pharmacogenetics 11, 545-550.
51. 2C serotonin receptors. Nature 374, 542-546.
52. Tsai SJ, CJ Hong, YW-Y Yu, C Lin, H Song, H Lai and K Yang (2000) Association study of a functional serotonin transporter gene polymorphism with schizophrenia, psychopathology and clozapine response. Schizophr. Res. 44, 177-181.
53. Tsai SJ, CJ Hong, YW Yu and CH Lin (2002) 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 360, 1790.
54. 4 receptor variants in the human population. Nature 358, 149-152.
55. Vojvoda D, K Grimmell, M Sernyak and CM Mazure (1996) Monozygotic twins concordant for response to clozapine. Lancet 347, 61.
56. Yu YW, SJ Tsai, CH Lin, CP Hsu, KH Yang and CJ Hong (1999) Serotonin-6 receptor variant (C267T) and clinical response to clozapine. NeuroReport 10, 1231-1233.